Novartis AG ROA Ratio 2011-2026 | NVS

Annual ROA Ratio Novartis AG

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	18.22	6.32	9.91	8.66	5.79	5.16	13.52	8.14	7.27	7.65	7.76

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
18.22	5.16	8.95

Quarterly ROA Ratio Novartis AG

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
2.76	1.38	3.71	4.67	4.67	2.33	3.84	3.02	3.02	1.51	7.36	11.69	11.69	5.85	11.32	10.94	10.94	5.47	5.47	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
11.69	1.38	5.87

ROA Ratio of other stocks in the Biotechnology industry

Issuer	ROA Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-20.13	-	2.43 %	$ 254 M	Germany
Heron Therapeutics HRTX	-7.89	$ 0.8	2.7 %	$ 133 M	USA
Amphastar Pharmaceuticals AMPH	6.02	$ 19.23	-1.38 %	$ 899 M	USA
Altimmune ALT	-31.47	$ 3.44	2.99 %	$ 303 M	USA
Aytu BioScience AYTU	-10.92	$ 2.63	0.77 %	$ 16.5 M	USA
I-Mab IMAB	7.43	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	3.33	-	-	$ 40.3 B	USA
Genfit SA GNFT	23.87	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-89.6	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-35.36	$ 218.06	-1.72 %	$ 5 B	Danmark
Midatech Pharma plc MTP	-42.28	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-53.39	-	-1.52 %	$ 24.7 M	USA
Incyte Corporation INCY	18.49	$ 90.45	-0.36 %	$ 17.7 B	USA
Applied Genetic Technologies Corporation AGTC	-27.57	-	-	$ 26.5 M	USA
Inovio Pharmaceuticals INO	-79.04	$ 1.61	1.9 %	$ 35.7 M	USA
ARCA biopharma ABIO	-21.14	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-10.45	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-123.72	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	-232.99	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-11.27	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-101.11	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	-13.29	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	4.82	-	-	-	Russia
Inventiva S.A. IVA	-40.69	$ 6.08	5.19 %	$ 138 M	France
Avenue Therapeutics ATXI	-437.72	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	-72.8	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-225.71	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-289.96	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	-489.29	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	-49.04	$ 12.84	0.78 %	$ 774 M	USA
Atreca BCEL	-62.67	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	26.14	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	3.5	-	0.49 %	$ 251 B	Cayman-islands
KalVista Pharmaceuticals KALV	-73.15	$ 16.6	-2.35 %	$ 824 M	Britain
Kamada Ltd. KMDA	-0.7	$ 8.2	-0.61 %	$ 260 M	Israel
Calithera Biosciences CALA	-177.73	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	-94.17	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-30.95	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	-249.92	-	-74.18 %	$ 955 K	USA
Karyopharm Therapeutics KPTI	-46.48	$ 6.66	-12.71 %	$ 812 K	USA
Keros Therapeutics KROS	25.74	$ 11.24	2.55 %	$ 418 M	USA
Checkpoint Therapeutics CKPT	-752.78	-	-	$ 169 M	USA
Clovis Oncology CLVS	-55.94	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	-19.95	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-35.55	-	-	$ 867 M	Germany
Longeveron LGVN	-221.26	$ 0.95	-2.71 %	$ 16.7 B	USA
Denali Therapeutics DNLI	-30.77	$ 21.09	4.56 %	$ 3.47 B	USA
Akero Therapeutics AKRO	-30.52	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	-50.45	$ 4.42	4.25 %	$ 734 M	Canada
Akouos AKUS	-31.09	-	0.23 %	$ 488 M	USA